Genome Compiler Ltd.

www.genomecompiler.com

Now Twist Bioscience Israel

High-Tech Company

Acquired by Twist Bioscience

TECH VERTICALS

Biotechnology, CAD, Digital Health, Healthcare IT, Healthtech, Life Sciences, MedTech, Software

General Data

Sector	Digital Health
Company Stage:	Initial Revenues
Established	2011
Number of Employees	15

DESCRIPTION

Genome Compiler is a leader in computer aided design and collaboration platforms for the synthetic biology industry. Genome Compiler's CAD tool and marketplace platform allows scientists in the biotechnology, agriculture and pharmaceutical industries to design, debug and compile biological code, to develop better bio-based products faster.

The company provides an intuitive software platform for the rapid engineering of biology with its genomic manipulation tools and its optimal design experience. It supplies the industry with a comprehensive platform for all your synthetic biology needs. Customers will benefit from direct connections to an array of DNA synthesis providers, lab facilitiy services and an extensive suite of advanced bio-informatics tools and genetic repositories, all in one platform.

TECHNOLOGY

Software platform that provides support for the complete development cycle of genetic engineering projects with an emphasis on assuring public safety. The platform facilitates the design, construction, characterization, dissemination, and maintenance of new genetic devices and systems.

	TARGET MARKETS
	Biologists, Medical labs, Medical Facilities, Medical professionals, Scientists.

	BUSINESS MODEL
	B2C

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Law Firm

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	2 Kikar Habima
City	Tel Aviv
Country	Israel
Zip	6425322

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Dr. Omri Amirav-Drory	Co-Founder
Mr. Nir Ben-Moshe	Co-Founder
Mr. Yogev Debbi	Co-Founder	Twist Bioscience Israel (General Manager, Israel R&D Center)
Mr. Roy Nevo	Co-Founder	Twist Bioscience Israel (Senior Director of Digital Product Development)

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Apr. 06, 2016

Initial Revenues

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

First Round

Jun. 01, 2015

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	High-Tech Company	abCDe	Led the round
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	General Accelerator	abCDe

Seed

Oct. 01, 2013

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	High-Tech Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	General Accelerator	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jul. 08, 2014

R&D

abCDe

Genome Compiler and Amyris (Emeryville, CA) will develop Biofab – synthetic biology software platform-as-a-service.

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Bi-National Fund	abCDe

Last Updated:	abCDe
IVC Number:	abCDe